Mixed hydroxypyridinonate ligands as iron chelators

Area of Science:

• Coordination Chemistry
• Supramolecular Chemistry
• Medicinal Inorganic Chemistry

Background:

• Iron(III) sequestration is crucial for managing iron overload disorders.
• Hydroxypyridinonate (HOPO) ligands are effective iron chelators.
• Developing novel ligands with tailored properties is essential for therapeutic applications.

Purpose of the Study:

• To synthesize and characterize new heteropodate ligands based on the TREN-Me-3,2-HOPO platform.
• To evaluate the iron(III) and iron(II) binding affinities of these novel ligands.
• To explore the potential of these ligands as iron sequestering agents for medical use.

Main Methods:

• Synthesis of novel ligands: TREN-Me-3,2-HOPOIAM and TREN-Me-3,2-HOPOTAM.
• X-ray diffraction for structural characterization of ferric complexes.
• Spectroscopic and electrochemical methods to determine aqueous coordination chemistry and formation constants.

Main Results:

• Fe[TREN-Me-3,2-HOPOIAM] and Fe[TREN-Me-3,2-HOPOTAM] ferric complexes were structurally characterized.
• High log formation constants were determined for ferric complexes (up to 38.45) and ferrous complexes (up to 13.7).
• Detailed speciation as a function of pH and redox activity was established.

Conclusions:

• The synthesized heteropodate ligands exhibit strong iron-binding capabilities.
• These ligands represent a promising new class for iron chelation therapy.
• Systematic variation of ligand properties allows for optimization for medical and other applications.